{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:10:41Z","timestamp":1771654241866,"version":"3.50.1"},"reference-count":67,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Background: Mutation of the TP53 gene is one of the major drivers of myelodysplastic neoplasias (MDS) and acute myeloid leukemia with myelodysplasia-related changes (AML-MR). TP53 mutations present in these hematopoietic malignancies form a distinct molecular genetic cluster with a worse prognosis than without the alteration. However, besides well-characterized hot-spot variants, a significant proportion of TP53 alterations are of uncertain clinical significance. Methods: To enlighten so far unknown aspects, bone-marrow samples from altogether 77 patients are analyzed retrospectively with the diagnosis of AML-MR (26 cases), MDS-IB (12 cases), and MDS-LB (39 cases) according to WHO 2022 guidelines. Next-generation sequencing results are correlated with histological, cytogenetic, and survival data. Results: Twenty out of the 30 TP53 mutation types detected by NGS are not categorized in current public databases; thus, their clinical significance remained mysterious. Because of the interpretation difficulties and the absence of clinical correlations, pathogenicity is established based on in silico approaches. The 12 pathogenicity classification systems, as well as protein stability, protein\u2013DNA, protein\u2013protein interaction, and post-translational modification analyses are applied. We found statistically significant differences between AML\/MDS groups considering p53 pathogenicity, protein structural changes, and overall survival. The largest number of abnormalities with the most severe consequences are found in AML-MR cases. Conclusions: These molecular and in silico protein data further support that MDS with increased-blast (MDS-IB) is an intermediate group between AML-MR and MDS with low-blast (MDS-LB) patients, which frequently progresses to AML and is therefore considered a pre-leukemic condition.<\/jats:p>","DOI":"10.3390\/cells11213475","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T03:11:21Z","timestamp":1667445081000},"page":"3475","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Deep Molecular and In Silico Protein Analysis of p53 Alteration in Myelodysplastic Neoplasia and Acute Myeloid Leukemia"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3608-7465","authenticated-orcid":false,"given":"Krist\u00f3f","family":"Madar\u00e1sz","sequence":"first","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6079-5621","authenticated-orcid":false,"given":"J\u00e1nos Andr\u00e1s","family":"M\u00f3ty\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Bedekovics","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zs\u00f3fia","family":"Milt\u00e9nyi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9178-5282","authenticated-orcid":false,"given":"Anik\u00f3","family":"Ujfalusi","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e1bor","family":"M\u00e9hes","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1052-8680","authenticated-orcid":false,"given":"Attila","family":"Mok\u00e1nszki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1182\/bloodadvances.2018022434","article-title":"Do Next-Generation Sequencing Results Drive Diagnostic and Therapeutic Decisions in MDS?","volume":"3","author":"Thol","year":"2019","journal-title":"Blood Adv."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc2693","article-title":"When Mutants Gain New Powers: News from the Mutant P53 Field","volume":"9","author":"Brosh","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrc2723","article-title":"The First 30 Years of P53: Growing Ever More Complex","volume":"9","author":"Levine","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","first-page":"3551","article-title":"Database of P53 Gene Somatic Mutations in Human Tumors and Cell Lines","volume":"22","author":"Hollstein","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","article-title":"P53, the Cellular Gatekeeper for Growth and Division","volume":"88","author":"Levine","year":"1997","journal-title":"Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/humu.23035","article-title":"TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data","volume":"37","author":"Bouaoun","year":"2016","journal-title":"Hum. Mutat."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/carcin\/bgs145","article-title":"P53 N-Terminal Phosphorylation: A Defining Layer of Complex Regulation","volume":"33","author":"Jenkins","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/bjh.12203","article-title":"TP53 Mutations in Myelodysplastic Syndrome Are Strongly Correlated with Aberrations of Chromosome 5, and Correlate with Adverse Prognosis","volume":"160","author":"Kulasekararaj","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/leu.2008.143","article-title":"Mutations of the TP53 Gene in Acute Myeloid Leukemia Are Strongly Associated with a Complex Aberrant Karyotype","volume":"22","author":"Haferlach","year":"2008","journal-title":"Leukemia"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","article-title":"Clinical Effect of Point Mutations in Myelodysplastic Syndromes","volume":"364","author":"Bejar","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and Biological Implications of Driver Mutations in Myelodysplastic Syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1073\/pnas.1914677117","article-title":"Improved Protein Structure Prediction Using Predicted Interresidue Orientations","volume":"117","author":"Yang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.abj8754","article-title":"Accurate Prediction of Protein Structures and Interactions Using a Three-Track Neural Network","volume":"373","author":"Baek","year":"2021","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"D512","DOI":"10.1093\/nar\/gku1267","article-title":"PhosphoSitePlus, 2014: Mutations, PTMs and Recalibrations","volume":"43","author":"Hornbeck","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"W297","DOI":"10.1093\/nar\/gkab408","article-title":"IUPred3: Prediction of Protein Disorder Enhanced with Unambiguous Experimental Annotation and Visualization of Evolutionary Conservation","volume":"49","author":"Pajkos","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0076-6879(96)66034-0","article-title":"[32] GOR Method for Predicting Protein Secondary Structure from Amino Acid Sequence","volume":"266","author":"Garnier","year":"1996","journal-title":"Methods Enzymol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"W306","DOI":"10.1093\/nar\/gki375","article-title":"I-Mutant2.0: Predicting Stability Changes upon Mutation from the Protein Sequence or Structure","volume":"33","author":"Capriotti","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Montanucci, L., Capriotti, E., Frank, Y., Ben-Tal, N., and Fariselli, P. (2019). DDGun: An Untrained Method for the Prediction of Protein Stability Changes upon Single and Multiple Point Variations. BMC Bioinform., 20.","DOI":"10.1186\/s12859-019-2923-1"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"W222","DOI":"10.1093\/nar\/gkac325","article-title":"DDGun: An Untrained Predictor of Protein Stability Changes upon Amino Acid Variants","volume":"50","author":"Montanucci","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/pro.3942","article-title":"DynaMut2: Assessing Changes in Stability and Flexibility upon Single and Multiple Point Missense Mutations","volume":"30","author":"Rodrigues","year":"2021","journal-title":"Protein Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.str.2018.06.006","article-title":"New Insights into the Role of DNA Shape on Its Recognition by P53 Proteins","volume":"26","author":"Golovenko","year":"2018","journal-title":"Structure"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1107\/S0907444997006550","article-title":"Crystallization and Structure Solution of P53 (Residues 326\u2013356) by Molecular Replacement Using an NMR Model as Template","volume":"54","author":"Mittl","year":"1998","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1126\/science.7878469","article-title":"Crystal Structure of the Tetramerization Domain of the P53 Tumor Suppressor at 1.7 Angstroms","volume":"267","author":"Jeffrey","year":"1995","journal-title":"Science"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nsmb1067","article-title":"Molecular Recognition of P53 and MDM2 by USP7\/HAUSP","volume":"13","author":"Sheng","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.molcel.2005.02.022","article-title":"Mechanism of Sirtuin Inhibition by Nicotinamide: Altering the NAD(+) Cosubstrate Specificity of a Sir2 Enzyme","volume":"17","author":"Avalos","year":"2005","journal-title":"Mol. Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly Accurate Protein Structure Prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold Protein Structure Database: Massively Expanding the Structural Coverage of Protein-Sequence Space with High-Accuracy Models","volume":"50","author":"Varadi","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1073\/pnas.0607286103","article-title":"Structural Basis for Understanding Oncogenic P53 Mutations and Designing Rescue Drugs","volume":"103","author":"Joerger","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/sj.onc.1203434","article-title":"Quantitative Analysis of Residual Folding and DNA Binding in Mutant P53 Core Domain: Definition of Mutant States for Rescue in Cancer Therapy","volume":"19","author":"Bullock","year":"2000","journal-title":"Oncogene"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"W338","DOI":"10.1093\/nar\/gkz383","article-title":"MCSM-PPI2: Predicting the Effects of Mutations on Protein\u2013Protein Interactions","volume":"47","author":"Rodrigues","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.8023159","article-title":"High-Resolution Structure of the Oligomerization Domain of P53 by Multidimensional NMR","volume":"265","author":"Clore","year":"1994","journal-title":"Science"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nsb0495-321","article-title":"Refined Solution Structure of the Oligomerization Domain of the Tumour Suppressor P53","volume":"2","author":"Clore","year":"1995","journal-title":"Nat. Struct. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"W241","DOI":"10.1093\/nar\/gkx236","article-title":"MCSM\u2013NA: Predicting the Effects of Mutations on Protein\u2013Nucleic Acids Interactions","volume":"45","author":"Pires","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s41418-022-00976-3","article-title":"The TP53 Database: Transition from the International Agency for Research on Cancer to the US National Cancer Institute","volume":"29","author":"Lee","year":"2022","journal-title":"Cell Death Differ."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/nar\/gkj518","article-title":"Computational Approaches for Predicting the Biological Effect of P53 Missense Mutations: A Comparison of Three Sequence Analysis Based Methods","volume":"34","author":"Mathe","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jmg.2005.033878","article-title":"Comprehensive Statistical Study of 452 BRCA1 Missense Substitutions with Classification of Eight Recurrent Substitutions as Neutral","volume":"43","author":"Tavtigian","year":"2006","journal-title":"J. Med. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/humu.23158","article-title":"PERCH: A Unified Framework for Disease Gene Prioritization","volume":"38","author":"Feng","year":"2017","journal-title":"Hum. Mutat."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/humu.23553","article-title":"Improved, ACMG-Compliant, in Silico Prediction of Pathogenicity for Missense Substitutions Encoded by TP53 Variants","volume":"39","author":"Fortuno","year":"2018","journal-title":"Hum. Mutat."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1101\/gr.176601","article-title":"Predicting Deleterious Amino Acid Substitutions","volume":"11","author":"Ng","year":"2001","journal-title":"Genome Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A Method and Server for Predicting Damaging Missense Mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"8424","DOI":"10.1073\/pnas.1431692100","article-title":"Understanding the Function-Structure and Function-Mutation Relationships of P53 Tumor Suppressor Protein by High-Resolution Missense Mutation Analysis","volume":"100","author":"Kato","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41588-018-0204-y","article-title":"Mutational Processes Shape the Landscape of TP53 Mutations in Human Cancer","volume":"50","author":"Giacomelli","year":"2018","journal-title":"Nat. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/carcin\/bgl132","article-title":"Inactive Full-Length P53 Mutants Lacking Dominant Wild-Type P53 Inhibition Highlight Loss of Heterozygosity as an Important Aspect of P53 Status in Human Cancers","volume":"28","author":"Dearth","year":"2007","journal-title":"Carcinogenesis"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1158\/1541-7786.MCR-10-0496","article-title":"Dominant-Negative Features of Mutant TP53 in Germline Carriers Have Limited Impact on Cancer Outcomes","volume":"9","author":"Monti","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: Public Archive of Relationships among Sequence Variation and Human Phenotype","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: Public Archive of Interpretations of Clinically Relevant Variants","volume":"44","author":"Landrum","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/humu.23641","article-title":"ClinVar at Five Years: Delivering on the Promise","volume":"39","author":"Landrum","year":"2018","journal-title":"Hum. Mutat."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: Improving Access to Variant Interpretations and Supporting Evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"D835","DOI":"10.1093\/nar\/gkz972","article-title":"ClinVar: Improvements to Accessing Data","volume":"48","author":"Landrum","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.ajhg.2021.08.012","article-title":"Improved Pathogenicity Prediction for Rare Human Missense Variants","volume":"108","author":"Wu","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"W247","DOI":"10.1093\/nar\/gkx369","article-title":"PhD-SNPg: A Webserver and Lightweight Tool for Scoring Single Nucleotide Variants","volume":"45","author":"Capriotti","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bioinformatics\/btx536","article-title":"FATHMM-XF: Accurate Prediction of Pathogenic Point Mutations via Extended Features","volume":"34","author":"Rogers","year":"2018","journal-title":"Bioinformatics"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Cumbo, C., Tota, G., Anelli, L., Zagaria, A., Specchia, G., and Albano, F. (2020). TP53 in Myelodysplastic Syndromes: Recent Biological and Clinical Findings. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103432"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.leukres.2014.03.012","article-title":"Prognostic Value of TP53 Gene Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia Treated with Azacitidine","volume":"38","author":"Bally","year":"2014","journal-title":"Leuk. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/leu.2013.336","article-title":"Landscape of Genetic Lesions in 944 Patients with Myelodysplastic Syndromes","volume":"28","author":"Haferlach","year":"2014","journal-title":"Leukemia"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/s41375-018-0351-2","article-title":"TP53 Mutation Status Divides Myelodysplastic Syndromes with Complex Karyotypes into Distinct Prognostic Subgroups","volume":"33","author":"Haase","year":"2019","journal-title":"Leukemia"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/s41591-020-1008-z","article-title":"Implications of TP53 Allelic State for Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes","volume":"26","author":"Bernard","year":"2020","journal-title":"Nat. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/leu.2015.304","article-title":"Impact of TP53 Mutation Variant Allele Frequency on Phenotype and Outcomes in Myelodysplastic Syndromes","volume":"30","author":"Sallman","year":"2016","journal-title":"Leukemia"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/leu.2016.74","article-title":"High Prevalence and Allele Burden-Independent Prognostic Importance of P53 Mutations in an Inner-City MDS\/AML Cohort","volume":"30","author":"Goel","year":"2016","journal-title":"Leukemia"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrclinonc.2017.151","article-title":"Therapeutic Targeting of P53: All Mutants Are Equal, but Some Mutants Are More Equal than Others","volume":"15","author":"Sabapathy","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1046\/j.1365-2141.1999.01256.x","article-title":"Molecular Evolution of Acute Myeloid Leukaemia in Relapse: Unstable N-ras and FLT3 Genes Compared with P53 Gene","volume":"104","author":"Nakano","year":"1999","journal-title":"Br. J. Haematol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.0141-9854.2003.00574.x","article-title":"Near-Triploidy and near-Tetraploidy in Hematological Malignancies and Mutation of the P53 Gene","volume":"26","author":"Watanabe","year":"2004","journal-title":"Clin. Lab. Haematol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1073\/pnas.0812256106","article-title":"Phosphorylation of P53 by I\u03baB Kinase 2 Promotes Its Degradation by \u03b2-TrCP","volume":"106","author":"Xia","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1158\/0008-5472.CAN-15-3373","article-title":"PAK4 Phosphorylates P53 at Serine 215 to Promote Liver Cancer Metastasis","volume":"76","author":"Xu","year":"2016","journal-title":"Cancer Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1158\/0008-5472.CAN-04-2935","article-title":"Lack of Correlation between P53-Dependent Transcriptional Activity and the Ability to Induce Apoptosis among 179 Mutant P53s","volume":"65","author":"Kakudo","year":"2005","journal-title":"Cancer Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"6976","DOI":"10.1038\/sj.onc.1208839","article-title":"The Relationship among P53 Oligomer Formation, Structure and Transcriptional Activity Using a Comprehensive Missense Mutation Library","volume":"24","author":"Kawaguchi","year":"2005","journal-title":"Oncogene"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/21\/3475\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:09:35Z","timestamp":1760144975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/21\/3475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":67,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["cells11213475"],"URL":"https:\/\/doi.org\/10.3390\/cells11213475","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]}}}